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 Abstract 
 Background: Atrial fibrillation (AF) is a major cause of stroke. Therefore, all patients with isch-
emic stroke or transient ischemic attack (TIA) should be examined with 12-lead electrocardio-
gram (ECG) and continuous monitoring to detect AF. Current guidelines recommend at least 
24 h continuous ECG monitoring, which is primarily based on studies investigating patients 
with ischemic stroke. The aim of our study was to investigate the diagnostic yield of 12-lead 
ECG and Holter monitoring in patients with TIA.  Methods: We retrospectively investigated all 
patients diagnosed with TIA at Odense University Hospital, Denmark, from January 1, 2014 to 
December 31, 2014. TIA was a clinical diagnosis according to the WHO definition. Patients 
received admission ECG and 72-hour Holter monitoring after discharge.  Results: 171 patients 
without known AF were diagnosed with TIA. Four (2.3%) were diagnosed with AF on admis-
sion ECG. Another 2 (1.2%) were diagnosed with AF on Holter monitoring. In total, 6 patients 
(3.5%) were diagnosed with AF. Patients with AF were significantly older (mean age 79.4 [95% 
CI 65.1–93.6] years) than patients without AF (mean age 67.6 [95% CI 65.6–69.5] years) but 
otherwise showed no difference in baseline characteristics.  Conclusion: In this retrospective 
study, patients with TIA had a low incidence of AF detected with ECG and 72-hour Holter 
monitoring. Prospective studies are needed to confirm these findings. 
 © 2016 The Author(s)
Published by S. Karger AG, Basel 
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 Introduction 
 Atrial fibrillation (AF) is the most frequent cardiac source of emboli and a major cause of 
stroke  [1, 2] . Therefore, efforts should be made to detect AF, so that patients with prior stroke 
or transient ischemic attack (TIA), who per se are at high thromboembolic risk, can be treated 
appropriately with oral anticoagulants to reduce this risk  [3] . If AF is persistent, the diagnosis 
will easily be made by taking a 12-lead electrocardiogram (ECG). Unfortunately, AF often is 
paroxysmal and can only be detected by long-term ECG monitoring. Current guidelines 
recommend 24-hour Holter monitoring (HM) if cardiac arrhythmias are suspected or if the 
cause of stroke is unknown  [4] .
 During recent years, a lot of studies have investigated different ECG monitoring strat-
egies in patients with stroke or TIA. In a meta-analysis, Sposato et al.  [5] analyzed 50 studies 
including 11,658 patients and found new-onset AF in 12.2% diagnosed during the in-hospital 
stay by admission ECG, serial ECGs, continuous cardiac telemetry, and in-hospital HM. 
Admission ECG alone yielded 7.7%. Another 10.7% of patients were diagnosed with AF by 
ambulatory HM after discharge. The vast majority of the studies in this meta-analysis predom-
inantly included stroke patients, whereas patients with TIA were either excluded or consti-
tuted only a minority of up to 20% of the total number of included patients. Moreover, one 
can speculate whether the same monitoring strategies used in stroke patients might also be 
suitable for patients with TIA.
 Thus, the aim of this study was to determine the detection rate of previously undiagnosed 
AF in patients with TIA using 12-lead ECG on admission and 72-hour HM after discharge and 
then compare our findings with other studies investigating pure cohorts of TIA patients.
 Methods 
 We retrospectively assessed all consecutive patients diagnosed with TIA or retinal TIA 
(amaurosis fugax) (ICD10, G45.9, and G45.3) at the Department of Neurology, Odense 
University Hospital from January 1, 2014 to December 31, 2014. Although there also were 
data available for the end of 2013 and the beginning of 2015, we chose only to include those 
admitted in 2014 to avoid influence of the seasonal variation in AF incidence  [6, 7] . The study 
was approved by the Regional Scientific Ethical Committees for Southern Denmark and the 
Danish Data Protection Agency.
 Clinical Management 
 Both in- and outpatients were included. Patients with suspected TIA with symptom onset 
<24 h were usually referred to acute hospital admission, whereas those with symptom onset 
>24 h were referred to the TIA outpatient clinic. Patients were referred to the hospital by 
either primary care physicians or emergency physicians/paramedics, if they suspected 
ischemic stroke. The emergency department or other medical specialties such as ophthal-
mologists also referred patients with suspected TIA. The initial investigation, regardless of 
admission type, included a consultation with a neurologist, a physical examination, blood 
samples, brain CT or MRI, 12-lead ECG, and carotid ultrasound.
 Diagnosis of Transient Ischemic Attack 
 TIA was a clinical diagnosis and based on the definition by The World Health Organi-
zation as “rapidly developed clinical signs of focal or global disturbance of cerebral function, 
lasting less than 24 h, with no apparent non-vascular cause”  [8] , regardless of findings on 
brain imaging. Patients who received systemic thrombolysis or other revascularization 
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procedures were excluded. Patients diagnosed with TIA but not living in the catchment area 
of Odense University Hospital were excluded as well, since these patients underwent further 
examinations at their local hospital and therefore we were unable to access the results.
 After a thorough investigation, the neurologist classified the patient as having a TIA or a 
TIA mimic. This study only focuses on those patients who were classified as having TIA or 
retinal TIA. Patients with a confirmed diagnosis received antiplatelet therapy and were 
referred for HM and further cardiac evaluation.
 Referral for Cardiac Evaluation 
 Patients without previously known AF or without AF on standard ECG were referred to 
72-hour HM. The Holter monitor (Lifecard CF, Spacelabs Healthcare) was connected with 4 
electrodes, which were attached to the chest surface. A continuous two-channel ECG was 
stored on a CompactFlash card with a maximum capacity of 7 days. All Holter recordings were 
analyzed by trained personnel using a dedicated software (Pathfinder SL, Spacelabs 
Healthcare), and the reports were reviewed by an experienced electrophysiologist. Transtho-
racic echocardiography was performed if patients were <65 years of age or if the referring 
physician suspected a cardiac source of embolism or heart disease. Transesophageal echocar-
diography was done if a suspected cardiac source of embolism was found on transthoracic 
echocardiography. Smaller atrial septal defects and patent foramen ovale were not considered 
cardiac sources of embolism, as their role in embolic stroke or TIA remains unclear  [9, 10] .
 AF was defined as irregularly irregular heart rhythm with the absence of P waves and/
or presence of F waves either on admission ECG or HM. An experienced cardiologist confirmed 
all diagnoses of AF regardless of monitoring type.
 Patient Characteristics 
 Hypertension was defined as receiving antihypertensive treatment. Hyperlipidemia was 
defined as treatment with statins or other cholesterol-lowering drugs on admission or having 
a total cholesterol >5 mmol/L or LDL cholesterol >3 mmol/L. Diabetes was defined as 
treatment with antidiabetics on admission or HbA 1c >48 mmol/mol. Previous stroke was 
defined as a prior diagnosis of stroke due to focal neurologic symptoms with typical findings 
on brain imaging with or without residual symptoms. Smoking was defined as a history of 
current or former tobacco use. Ischemic heart disease was defined as prior myocardial 
infarction, prior CABG/PCI, or prior coronary angiography or other imaging techniques 
demonstrating coronary artery disease.
 Data Acquisition, Validity, and Statistical Analysis 
 Data were obtained from the patients’ electronic medical records. Prior to data collection, 
a report defined how each variable should be obtained. All data were entered into a database 
(Access 2010, Microsoft Corporation, Redmond, WA, USA) and subsequently analyzed using 
STATA 14 (StataCorp LP, College Station, TX, USA).
 Continuous variables were reported as mean with 95% confidence interval if data 
followed a normal distribution. Significance was tested using Students  t test. Non-normal 
continuous data were reported as median and range. Significance was tested using Wilcoxon 
Mann-Whitney U test. Binary variables were reported as percentages and analyzed using 
Fisher’s exact test. A two-sided  p value <0.05 was considered statistically significant.
 Identifying other Transient Ischemic Attack Studies 
 To compare our results with similar studies, we conducted a literature search in PubMed, 
Embase, and The Cochrane Library for studies reporting the detection rate of AF in a TIA 
population. We included only prospective studies, as these had predefined patient inclusion 
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criteria, and we wanted to avoid a possibly high incidence of AF due to selection bias. Studies 
regardless of language or publication date were eligible.
 Results 
 Between January 1, 2014 and December 31, 2014, 279 patients were diagnosed with TIA. 
In total, 44 patients were excluded because they were later characterized as TIA mimics ( n = 
10), had a history of AF ( n = 28), or had no ECG taken on admission ( n = 6), leaving 235 
patients eligible for study inclusion ( Fig. 1 ). An additional 64 patients were excluded, as they 
had no HM ( n = 52), Holter recording was unavailable for review ( n = 5), or they received 
in-hospital telemetry ( n = 7). In-hospital telemetry was rarely and inconsistently used 
throughout the study inclusion period and excluded because ECG data were unavailable for 
review.
 Table 1 shows the baseline characteristics of the entire cohort, patients with newly diag-
nosed AF (AF group), and those without AF (non-AF group), respectively. Patients in the AF 
group were significantly older with a mean age of 79.4 (95% confidence interval 65.1–93.6) 
years compared with 67.6 (95% confidence interval 65.6–69.5) years in the non-AF group
( p = 0.0276). There was no statistically significant difference regarding the other baseline 
characteristics. TIA constituted the majority of patients, as less than 10% had retinal TIA. 
Fifty-eight percent were treated in-hospital, while the remaining patients were later seen in 
the TIA outpatient clinic after a median delay of 4.5 days.
Patients diagnosed with TIA from
January 1, 2014 to December 31, 2014
(n = 279)
Patients eligible for study inclusion
(n = 235)
Admission ECG without AF
(n = 231)
Patients with 72-hour Holter monitoring
(n = 167)
AF on admission ECG
(n = 4)
Excluded (n = 44)
- Diagnosis later changed (n = 10)
- History of AF (n = 28)
- No admission ECG (n = 6)
Excluded (n = 64)
- No Holter monitoring performed (n = 52)
- Holter data unavailable (n = 5)
- Received in-hospital telemetry instead of Holter (n = 7)
 Fig. 1. Flowchart highlighting the patient selection process. TIA, transient ischemic attack; AF, atrial fibrilla-
tion; ECG, electrocardiogram. 
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 Detection of Atrial Fibrillation 
 New AF on admission ECG was found in 4 patients out of the initial 235 patients (1.7%). 
HM was done in 167 patients, and AF was found in 2 patients (1.2%). Excluding all patients 
not undergoing HM, we ended up with 171 patients. Six of them (3.5%) were diagnosed with 
AF by using ECG and 72-hour HM.
 Holter Monitoring 
 The median duration of HM was 71.7 h with a median delay from admission to HM of 48 
days. In general, all HM showed a good quality with a median percentage of unreadable data 
of 0.2% ( Table 2 ).
 HM was not performed in 52 patients (22.5%), mainly because patients did not show up, 
but some also had previous HM close to the event, which was why it was not deemed necessary 
to perform a new one. Some patients with dementia or nursing home residents with low func-
tional level were not offered HM because of inability to participate.
 Significant arrhythmias other than AF requiring either admission or further examina-
tions were found in 15 patients (9%), of which the most common was non-sustained 
ventricular tachycardia ( n = 12).
 Table 1.  Baseline characteristics of the study subjects
All patients
(n = 171) 
Non-AF group
(n = 165)
AF group
(n = 6)
p
Male gender 89 (52) 87 (52.7) 2 (33) 0.4284
Mean age, years 68 (66.1 – 70) 67.6 (65.6 – 69.5) 79.4 (65.1 – 93.6) 0.0276
Mean BMI 26.3 (25.7 – 26.9) 26.4 (25.7 – 27) 25.4 (21.8 – 29.1) 0.5649
Mean blood pressure, mm Hg 147/83 147/83 157/80 0.29/0.62
Index event
TIA 158 (92.7) 153 (92.7) 5 (83.3) 0.3823
Retinal TIA 13 (7.3) 12 (7.3) 1 (16.7) 0.3823
Admission type
In-patient 99 (58) 95 (57.6) 4 (66.7) 1
TIA clinic 72 (42) 70 (42.4) 2 (33.3) 1
Median delay to TIA clinic, days 4.5 [1 – 153] 4.5 [1 – 153] 27 [4 – 50] 0.28
Medical history
Hypertension 93 (54.4) 88 (53.3) 5 (83.3) 0.221
Diabetes 19 (11.1) 18 (10.9) 1 (16.7) 0.512
Hyperlipidemia 63 (36.8) 60 (36.4) 3 (50) 0.671
Previous stroke 31 (18.1) 31 (18.8) 0 (0) 0.5932
Ischemic heart disease 19 (11.1) 19 (11.5) 0 (0) 1
Smoking 90 (52.6) 86 (52.1) 4 (66.7) 0.392
Antiplatelet treatment at admission 59 (34.5) 59 (35.8) 0 (0) 0.094
OAC treatment at admission 3 (1.8) 3 (1.8) 0 (0) 1
Blood samples
Mean cholesterol, mmol/L 5.2 (5 –  5.4) 5.2 (5 – 5.4) 5.1 (3.6 – 6.6) 0.8421
Mean LDL, mmol/L 3.2 (3 – 3.4) 3.2 (3 – 3.4) 3.4 (2 – 4.8) 0.7273
Mean HbA1c, mmol/mol 38 [23 – 85] 37.5 [23 – 85] 38 [34 – 49] 0.7350
 Values in parentheses are percentages or 95% confidence intervals, and values in square brackets are 
ranges. BMI, body mass index; AF, atrial fibrillation; TIA, transient ischemic attack; OAC, oral anticoagulation 
therapy.
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 Cerebrovascular and Cardiac Diagnostic Imaging 
 Brain imaging was done in all patients. Brain CT was done in 165 patients (94.5%) and 
brain MRI in 67 patients (39.2%) ( Table 3 ). Carotid artery ultrasound was performed in 164 
patients (95.9%). Six of these patients (3.7%) had a significant carotid artery stenosis 
requiring carotid endarterectomy. Transthoracic echocardiography was performed in 112 
patients (65.5%) and did not reveal any thrombi or other cardiac source of emboli.
 In 7%, coronary angiography, cardiac computed tomography, or myocardial perfusion 
imaging was performed. The main reason for the examinations was non-sustained ventricular 
tachycardia detected on Holter monitoring or suspected angina pectoris.
 Table 2. Holter monitoring data
Patients with Holter 
monitoring (n = 167)
Atrial fibrillation found on Holter, any duration 2 (1.2)
Atrial fibrillation found on Holter, ≥30 s 1 (0.6)
Mean delay from admission to Holter, days 48 (43 – 54)
Median time from Holter to final analysis and patient information, days 13 [4 – 116]
Median length of Holter monitoring, h 71.7 [45.7 – 116]
Median percentage of unreadable Holter data 0.2 [0 – 37.6]
Median number of premature ventricular complexes 66 [0 – 123,366]
Median number of supraventricular extrasystoles 55 [0 – 21,533]
Median number of supraventricular tachycardias (not atrial fibrillation) <30 s 1 [0 – 208]
Significant arrhythmias 15 (8.8)
Sinus arrest 1 (0.6)
Second-degree atrioventricular block 2 (1.2)
Non-sustained ventricular tachycardia 12 (7.2)
Values in parentheses are percentages or 95% confidence intervals, and values in square brackets are 
ranges.
 Table 3. Diagnostic procedures
Study sample 
(n = 171)
Non-AF group
(n = 165)
AF group
(n = 6)
p
Cranial CT 165 (94.5) 159 (96.4) 6 (100) 1
Cranial MRI 67 (39.2) 66 (40) 1 (16.7) 0.406
Evidence of acute or old infarction on CT or MRI 63 (36.8) 60 (36.4) 3 (50) 0.671
Carotid ultrasound 164 (95.9) 159 (96.4) 5 (83.3) 0.2248
Significant carotid stenosis 9 (5.5) 8 (5.5) 1 (20) 0.2486
Carotid endarterectomy 6 (3) 5 (3) 1 (20) 0.1955
Thrombophilia 1 (0.6) 4 (0.6) 0 (0) 1
TTE 112 (65.5) 107 (64.8) 5 (83.3) 0.6656
TOE 7 (4.1) 7 (4.2) 0 (0) 1
Cardiac source of embolus found on TTE/TOE 0 (0) 0 (0) 0 (0) 1
Cardiac CT 4 (2.3) 4 (2.4) 0 (0) 1
Myocardial perfusion scintigraphy 2 (1.2) 2 (1.2) 0 (0) 1
Coronary angiography 6 (3.5) 6 (3.6) 0 (0) 1
Values are expressed as numbers with percentages in parentheses. CT, computed tomography; MRI, 
magnetic resonance imaging; TTE, transthoracic echocardiography; TOE; transesophageal echocardiography.
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 Literature Search of Similar Studies 
 Searching the online literature databases, we found five prospective studies focusing on 
patients with TIA ( Table 4 )  [11–15] . A total of 7,837 patients with a mean age of 69.2 years 
were included in these studies. All studies used the WHO definition of TIA. However, the 
methods of reporting the percentage of AF were largely differing. Three studies reported the 
percentage of patients with a history of AF prior to TIA being 17.3, 8.9, and 9.2%, respectively. 
Two other studies reported the total number of patients with AF including both history of AF 
and new AF being 25.7 and 17.2%, respectively. Perry et al.  [12] also reported the percentage 
of new AF (1.5%). In some of the studies, patients underwent continuous monitoring, but the 
type or duration was not always specified. None of the studies reported a definition of AF or 
who made the diagnosis.
 Discussion 
 In our study of 171 patients with TIA and no history of AF, we found 4 patients (2.3%) 
with new AF on admission ECG. AF was afterwards found in another 2 (1.2%) out of the 
remaining 167 patients undergoing HM. In total, 6 patients (3.5%) were diagnosed with new 
AF. Looking at the entire population screened and excluding TIA mimics ( n = 269), 28 patients 
(10.4%) had a history of AF.
 The proportion of patients with a history of AF is similar to those in the TIA studies by 
Perry et al.  [12] and von Weitzel-Mudersbach et al.  [13] , who reported a known AF percentage 
of 9.2 and 8.9%, respectively. Perry et al.  [12] found 1.5% of their patient population having 
new AF using admission ECG, which is similar to our results. Interestingly, we found only 2 
patients with AF in the 167 patients undergoing HM.
 Comparing our results with a mixed population of ischemic stroke and TIA patients in the 
meta-analysis by Sposato et al.  [5] , we found fewer patients with new AF on admission ECG 
(2.3 vs. 7.7%) and fewer patients with new AF on ambulatory monitoring (1.2 vs. 10.2%). 
There could be several possible explanations for these findings.
 Differences in Study Populations 
 The studies in the meta-analysis by Sposato et al.  [5] primarily included patients with 
ischemic stroke, although some had a minor proportion of patients with TIA as well. AF is 
known to cause severe ischemic strokes  [16] and the underlying pathophysiological mech-
anism is believed to be thrombus formation due to blood stasis, hypercoagulability, and endo-
thelial dysfunction in the left atrial appendage and subsequent embolization of the thrombus 
to the brain  [17] .
 Table 4. Prospective studies with TIA patients
First author [Ref.] Year n Age,
years
History
of AF, n (%)
New AF,
n (%)
Combined
AF, n (%)
Monitoring
methods
Al-Khaled [15] 2014 2,200 70.6 381 (17.3) – – –
Sheehan [14] 2010 443 70 112 (25.3) ECG and/or CM
von Weitzel-Mudersbach [13] 2012 203 66.3 18 (8.9) – – –
Perry [12] 2014 3,906 68 349 (9.2) 53 (1.5) 402 (10.3) ECG
Inoue [11] 2004 1,084 69.2 – – 186 (17.2) ECG and/or 24HM
AF, atrial fibrillation; ECG, electrocardiography; CM, continuous ECG monitoring; 24HM, 24-hour Holter monitoring.
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 In theory, TIA could be caused by micro-embolization from such a thrombus, but our data 
suggest that AF might be less common in patients with TIA and therefore less likely to be the 
cause. Even in ischemic stroke patients it is still being discussed whether or not AF is the 
cause of thrombus formation per se or just a marker of an underlying atrial pathology predis-
posing to thrombus formation  [18] . The only statistically significant difference between the 
AF and non-AF group in our study was age, which is also known to be the single most important 
risk factor for developing AF  [19] .
 Diagnosing Atrial Fibrillation 
 Another important factor to consider when comparing the low diagnostic yield of cardiac 
monitoring in our study population with other studies is the validity of the AF diagnosis. In 
our study, all ECGs and HMs were analyzed by an experienced electrophysiologist. An episode 
of AF on HM was defined as an episode with irregularly irregular rhythm regardless of length, 
although current guidelines  [20] recommend a minimum AF duration of 30 s. We chose to 
consider all AF episodes regardless of their duration because there is currently no convincing 
evidence that shorter episodes of AF are less dangerous than longer episodes in a population 
at high risk of stroke  [21] .
 None of the five prospective studies we identified from the literature had a clear defi-
nition of AF, and they did not state who made the diagnosis. AF is easy to diagnose on ECG, 
but it requires trained staff to distinguish AF from other atrial arrhythmias such as ectopic 
atrial tachycardia, sinus arrhythmia, and frequent premature atrial complexes. Oral antico-
agulant treatment in patients with ischemic stroke/TIA and AF reduces the risk of recurrent 
stroke, but if AF is misdiagnosed, however, the treatment could be potentially dangerous, 
putting the patients at unnecessary risk of hemorrhage. If AF is suspected, efforts should be 
made to confirm the diagnosis by consulting a cardiologist.
 Validity of Diagnosing Transient Ischemic Attack 
 Our low detection rate of AF could also be due to differences in the diagnostic criteria of 
TIA. It is estimated that around 50% of all patients with suspected TIA have “TIA mimics” 
 [22]. In our study, we only included patients with a final diagnosis of TIA, and only in a few, 
the diagnosis was later changed. We do not have data from the patients with suspected TIA 
who were finally diagnosed with TIA mimics. However, the majority of patients were seen by 
an experienced senior neurologist, which limits the possibility of including an excessive 
number of patients with TIA mimics in this study.
 Definition of Transient Ischemic Attack 
 At our institution, we use the WHO definition of TIA, which is a clinical diagnosis primarily 
based on a description of the symptoms as the neurological deficit often disappears before 
admission. A tissue-based definition of TIA is not routinely used, because the brain MRI 
capacity at our institution is a limiting factor. Patients with signs of new infarction on brain 
imaging could have been included in our study because their symptoms resolved within 24 h. 
On the other hand, we cannot rule out that some of these patients were diagnosed with stroke 
instead of TIA because brain MRI showed signs of infarction. There is no clear pattern which 
patients received brain MRI, brain CT, or both, but one could suspect that younger patients and 
patients with severe or longer-lasting neurological deficits were offered a brain MRI. If some 
of these patients were categorized as stroke and, therefore, not included in the study, this 
could be a possible cause of selection bias, which could explain our low incidence of AF.
 We identified our study population on the basis of a final clinical diagnosis of TIA or 
retinal TIA, and did not review all patients diagnosed with ischemic stroke to see whether or 
not the episode length was <24 h.
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 The American Heart Association and American Stroke Association published a scientific 
statement regarding TIA in 2009  [23] . They argued for a revision of the diagnostic criteria for 
TIA to include brain imaging, preferably brain MRI, to categorize all patients with signs of 
acute brain infarctions as ischemic stroke regardless of time criteria. This would simplify the 
diagnostic process and make a diagnosis of TIA more accurate. It was not possible in this 
study to use brain imaging for the selection of study participants because brain MRI was not 
systematically used throughout the study inclusion period.
 Atrial Fibrillation: Cause or Consequence? 
 It has been hypothesized that AF after stroke and TIA could be due to imbalance in the 
autonomic nervous system caused by cerebral ischemia  [24] . In other words, is AF the cause 
or the consequence of stroke or TIA? This hypothesis of neurogenically mediated AF could 
explain the low incidence of AF in patients with TIA compared to stroke. Stroke patients suffer 
more severe brain damage than patients with TIA resulting in autonomic imbalance which 
can affect the heart. In addition, the delay in our study from event to HM was 48 days. We 
could have missed AF episodes occurring shortly after TIA onset, especially if AF was trig-
gered by a temporary risk factor such as infection at the time of TIA or if AF was caused by 
autonomic imbalance caused by transient ischemia.
 Conclusion 
 In our study of 171 patients with TIA or retinal TIA with no history of AF, we found new 
AF in 3.5% by using admission ECG and 72-hour HM. The percentage of patients with a history 
of AF prior to the event was similar to other studies with the same population but markedly 
lower compared to patients with stroke. Clinicians should be aware that the incidence of AF 
is lower in patients with TIA than in those with stroke. The reason for low AF incidence could 
be due to AF and TIA diagnostic criteria, but also because all ECGs in our study were reviewed 
by a cardiologist to avoid misdiagnosing AF. The theory of neurogenically mediated AF could 
explain the low incidence of AF in patients with TIA, but prospective studies with clear defi-
nitions of TIA and AF are needed to confirm our results and test the hypothesis. In the 
meantime, all patients with confirmed AF and TIA should be treated with oral anticoagulants 
regardless of AF duration.
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